The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells

Oncogene
B L HarvatA M Jetten

Abstract

Interferon gamma (IFNgamma) induces growth arrest in normal human mammary epithelial cells by establishing a block during mid-G1 corresponding to the time when the retinoblastoma protein (Rb) would normally be inactivated by hyperphosphorylation. IFNgamma inhibits the kinase activities of cdk2, cdk4 and cdk6 within 24 h of treatment. Protein levels of the cdks and G1 cyclins do not change within this time period, although cdk4 levels are significantly reduced by 48 h. IFNgamma treatment induces p27Kip1 protein levels, presumably by a post-transcriptional mechanism as no change was observed in the mRNA levels. In addition, IFNgamma-induced inhibition of cdk2 and cyclin E-associated kinase activities is accompanied by a 4.5-fold or greater increase of p27Kip1 in cdk2 complexes. p27 may also have a role in the inhibition of cdk4/6 kinase activities, as p27 protein associated with these complexes was increase by 55-70% after IFNgamma. In mammary carcinoma cell lines which are resistant to growth inhibition by IFNgamma, p27 levels are not induced by IFNgamma nor is cdk2 kinase activity inhibited, despite high baseline levels of p27 in cdk2 complexes. However, exogenous expression of p27 in these cells induces growth arrest. In addit...Continue Reading

Citations

Mar 4, 2000·Journal of Cellular Physiology·A SgambatoI B Weinstein
Jan 4, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T YanoK Sugimachi
Apr 8, 1998·Current Opinion in Genetics & Development·S Mittnacht
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S ErkanliB Demirhan
Apr 4, 1998·American Journal of Respiratory Cell and Molecular Biology·H AdachiA M Jetten
Aug 15, 2013·Journal of Neurovirology·Kevin P EganStephen R Jennings
Nov 6, 2015·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Chiou-Feng LinYu-Chih Wang
Jan 19, 2006·The Journal of Investigative Dermatology·Gen NakanishiAnton M Jetten
Mar 11, 2004·The Journal of Investigative Dermatology·Marcin KortylewskiIris Behrmann
Sep 25, 2004·Journal of Cellular Physiology·Michele CaragliaAlberto Abbruzzese
Mar 8, 2011·The Journal of Allergy and Clinical Immunology·Mübeccel AkdisCezmi A Akdis
May 2, 2001·Gynecologic Oncology·L R NycumM J Birrer
Jul 24, 2001·Medical and Pediatric Oncology·T MatsuoC J Thiele
May 20, 2008·Molecular and Cellular Endocrinology·Teresa I CeseñaJessica Schwartz
Oct 16, 2015·PloS One·Bose S KochupurakkalJ Dirk Iglehart
May 29, 1999·The Journal of Biological Chemistry·J P O'RourkeJ DeWille
Feb 2, 2017·Journal of Biomedical Science·Chiou-Feng LinTsung-Ting Tsai
Dec 29, 2017·International Journal of Molecular Sciences·Marija MojicYoshihiro Hayakawa
Jan 27, 2006·Molecular Biology of the Cell·Olga MoiseevaGerardo Ferbeyre
Oct 4, 2003·Journal of Leukocyte Biology·Kate SchroderDavid A Hume
Nov 6, 2018·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M Raza Zaidi
May 27, 2006·The Journal of Biological Chemistry·Makoto HoriuchiTakayuki Itoh
Oct 14, 2014·Vaccines·Shifeng Wang, Roy Curtiss
Jun 18, 2015·The Journal of Biological Chemistry·Kewei Xu, Rene E Harrison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.